New ventures or altering course of business due to failure from previous business means 90-99% chance of repeat failure and losing money at the expense of current investors. Happens all the time in OTC, the fact is 98% of businesses result in failure. But if a company wants an option to R/S to advance their current business due to success, by uplisting for all the benefits of uplisting (which includes benefits to current investors) then it's acceptable to have the 14c filing for that option.